British Journal of Pharmacology
© The British Pharmacological Society
Editor-in-Chief: Professor J.C. (Ian) McGrath
Impact Factor: 4.99
ISI Journal Citation Reports © Ranking: 2013: 21/254 (Pharmacology & Pharmacy)
Online ISSN: 1476-5381
Associated Title(s): British Journal of Clinical Pharmacology
Virtual Issue: Animal Models in Pharmacology Research
(content last updated March 2013)
BJP has collected together a series of articles on the use of animal models in pharmacology research. As each relevant article is published in BJP a link to it will be placed here to allow our readers to browse the entire series:
L Villa, R Buono, N Fossati, P Rigatti, F Montorsi, F Benigni, P Hedlund (2013) Effects by silodosin on the partially obstructed rat ureter in vivo and on human and rat isolated ureters. Br J Pharmacol, 169: 230–238
Bauer C, Banks M, Blough B and Negus S (2013) Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats. Br J Pharmacol, 168: 850–862.
Oertel BG and Lötsch J (2013) Clinical pharmacology of analgesics assessed with human experimental pain models: bridging basic and clinical research. Br J Pharmacol, 168: 534–553.
Hill A, Mercier M, Hill T, Glyn S, Jones N, Yamasaki Y, Futamura T, Duncan M, Stott C, Stephens G, Williams C and Whalley B (2012) Cannabidivarin is anticonvulsant in mouse and rat. Br J Pharmacol, 167: 1629–1642.
King AJF (2012) The use of animal models in diabetes research. Br J Pharmacol 166:877–894.
Son HJ, Lee JA, Shin N, Choi JH, Seo JW, Chi DY, Lee CS, Kim E-M, Choe H and Hwang O (2012) A novel compound PTIQ protects the nigral dopaminergic neurones in an animal model of Parkinson's disease induced by MPTP. Br J Pharmacol, 165: 2213–2227.
Percie du Sert N, Holmes AM, Wallis R and Andrews PLR (2012) Predicting the emetic liability of novel chemical entities: a comparative study. Br J Pharmacol, 165: 1848–1867.
Themed Issue: Translational Neuropharmacology - Using Appropriate Animal Models to Guide Clinical Drug Development. Guest Editor: A Richard Green
Morgan MM and Christie MJ (2011) Analysis of opioid efficacy, tolerance, addiction and dependence from cell culture to human. Br J Pharmacol, 164: 1322–1334.
Vickers SP, Jackson HC and Cheetham SC (2011) The utility of animal models to evaluate novel anti-obesity agents. Br J Pharmacol, 164: 1248–1262.
Graham BM, Langton JM and Richardson R (2011) Pharmacological enhancement of fear reduction: preclinical models. Br J Pharmacol, 164: 1230–1247.
Berge O-G (2011) Predictive validity of behavioural animal models for chronic pain. Br J Pharmacol, 164: 1195–1206.
Russell JT (2011) Imaging calcium signals in vivo: a powerful tool in physiology and pharmacology. Br J Pharmacol, 163: 1605–1625.
Emerson M (2010) Refinement, reduction and replacement approaches to in vivo cardiovascular research. Br J Pharmacol, 161: 749–754.
Hardaker E, Freeman M, Dale N, Bahra P, Raza F, Banner K and Poll C (2010) Exposing rodents to a combination of tobacco smoke and lipopolysaccharide results in an exaggerated inflammatory response in the lung. Br J Pharmacol, 160: 1985–1996.
Kilkenny C, Browne W, Cuthill IC, Emerson M and Altman DG (2010) The ARRIVE guidelines. Br J Pharmacol, 160: 1577–1579.
McGrath JC, Drummond GB, McLachlan EM, Kilkenny C and Wainwright CL (2010) Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol, 160: 1573–1576.
Panlilio LV, Justinova Z and Goldberg SR (2010) Animal models of cannabinoid reward. Br J Pharmacol, 160: 499–510.
Giacomotto J and Ségalat L (2010) High-throughput screening and small animal models, where are we? Br J Pharmacol, 160: 204–216.
Holmes AM, Rudd JA, Tattersall FD, Aziz Q and Andrews PLR (2009) Opportunities for the replacement of animals in the study of nausea and vomiting. Br J Pharmacol, 157: 865–880.
Robinson V (2009) Less is more: reducing the reliance on animal models for nausea and vomiting research. Br J Pharmacol, 157: 863–864.
McMurray G, Casey JH and Naylor AM (2006) Animal models in urological disease and sexual dysfunction. Br J Pharmacol, 147: S62–S79.